IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Brazil

  • ID: 1408475
  • Report
  • Region: Brazil
  • 44 Pages
  • IMS Health
1 of 3

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Note: Product cover images may vary from those shown
2 of 3

BRAZIL

1. Healthcare System

  • Facts & Figures
  • Market Indicators
  • Provision & Funding
  • Healthcare System
  • Decentralisation
  • Healthcare Funding
  • Healthcare Services
  • Private Health Insurance.

2. Pricing

  • Prescription Drugs
  • Pricing Procedure
  • Drug Categories
  • Application
  • Pricing Methodology
  • Timelines
  • Appeals
  • Local Manufacturing Agreements
  • Generic Drugs
  • Generics
  • Similares
  • Hospital Drugs
  • Mandatory Discount
  • Other Discounts
  • Tendering
  • OTC Drugs

3. Reimbursement
Admission to Reimbursement
SUS Reimbursement Coverage

4. Rename

  • Popular Pharmacy Programme
  • Lawsuits
  • Private Health Plans
  • Positive, Negative and Neutral Lists
  • Reimbursement Categories
  • Reimbursement Prices
  • Hospital Reimbursement
  • Formularies
  • Funding
  • Changes in Reimbursement Status
  • Changes in Reimbursement Prices
  • Annual Price Adjustment Limits
  • Exceptional Price Adjustment
  • CAP Discounts
  • Sales Tax Adjustment

5. Pharmacoeconomics

  • Pharmacoeconomic Requirements
  • Pricing
  • Reimbursement

6. Price Build Up

  • Wholesalers
  • Margins
  • Background
  • Retail Pharmacies
  • Margins
  • Background
  • Regulations
  • Dispensing Doctors
  • Sales Tax
  • Sales Tax Changes
  • Recent Reform Proposals

7. Cost Containment

  • Industry Paybacks
  • Promotional Costs
  • Patient Co-payments
  • Prescribing Controls
  • National Therapeutic Formulary
  • Protocols and Guidelines
  • INN Prescribing
  • Hospital Sector
  • Generics
  • Substitution
  • Rules for Similares/Branded Copies
  • Rx-to-OTC Switches
  • OTC Sales
  • Parallel Trade

8. Future Developments

  • Outlook
  • Healthcare Budget
  • Healthcare Savings
  • Annual Price Adjustment
  • Sales Tax Reform Proposals
  • Orphan Drugs
  • Limitation of Lawsuits
  • Drug Traceability
  • National Programme for STD and AIDS
  • Popular Pharmacy Programme
  • Exceptional Price Adjustment
  • Advertising Ban

9. Names & Addresses

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll